{"news_desk": "Business", "print_page": "1", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By ANDREW POLLACK and CHAD BRAY", "person": [{"rank": 1, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}, {"rank": 2, "role": "reported", "firstname": "Chad", "organization": "", "lastname": "BRAY"}]}, "abstract": "Valeant Pharmaceuticals International will acquire Sprout Pharmaceuticals for about $1 billion; deal comes nearly week after Food and Drug Administration granted Sprout approval for Addyi, new libido-enhancing drug for women.", "type_of_material": "News", "word_count": "1117", "lead_paragraph": "The deal for Sprout Pharmaceuticals came after the Food and Drug Administration granted approval this week for Addyi, a new libido drug for women.", "pub_date": "2015-08-21T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Maker of Addyi, \u2018Female Viagra\u2019 Drug, Being Sold to Valeant for $1 Billion", "print_headline": "Valeant Buys Company That Makes Libido Drug "}, "snippet": "The deal for Sprout Pharmaceuticals came after the Food and Drug Administration granted approval this week for Addyi, a new libido drug for women.", "multimedia": [{"height": 126, "url": "images/2015/08/21/business/dbpix-sprout2/dbpix-sprout2-thumbWide-v2.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/08/21/business/dbpix-sprout2/dbpix-sprout2-thumbWide-v2.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 378, "url": "images/2015/08/21/business/dbpix-sprout2/dbpix-sprout2-articleLarge-v2.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "378", "xlarge": "images/2015/08/21/business/dbpix-sprout2/dbpix-sprout2-articleLarge-v2.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/08/21/business/dbpix-sprout2/dbpix-sprout2-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/08/21/business/dbpix-sprout2/dbpix-sprout2-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/08/21/business/dealbook/valeant-pharmaceuticals-to-buy-sprout-maker-of-addyi-female-viagra-drug.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Sprout Pharmaceuticals Inc", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Valeant Pharmaceuticals International Inc", "name": "organizations"}, {"rank": "3", "is_major": "N", "value": "Addyi (Drug)", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}], "blog": [], "_id": "55d5c40338f0d84ac8725c16", "source": "The New York Times"}